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The toroidal damage checkpoint complex Rad9–Rad1–Hus1 (9-1-1)
has been characterized as a sensor of DNA damage. Flap endonu-
clease 1 (FEN1) is a structure-specific nuclease involved both in
removing initiator RNA from Okazaki fragments and in DNA repair
pathways. FEN1 activity is stimulated by proliferating cell nuclear
antigen (PCNA), a toroidal sliding clamp that acts as a platform for
DNA replication and repair complexes. We show that 9-1-1 also
binds and stimulates FEN1. Stimulation is observed on a variety of
flap, nick, and gapped substrates simulating repair intermediates.
Blocking 9-1-1 entry to the double strands prevents a portion of
the stimulation. Like PCNA stimulation, 9-1-1 stimulation cannot
circumvent the tracking mechanism by which FEN1 enters the
substrate; however, 9-1-1 does not substitute for PCNA in the
stimulation of DNA polymerase . This suggests that 9-1-1 is a
damage-specific activator of FEN1.
DNA damage response  DNA replication
F lap endonuclease 1 (FEN1) is the primary nuclease involvedin the removal of the RNA primers from Okazaki fragments
(1). Deletion of the FEN1 gene in Saccharomyces cerevisiae
produces temperature-sensitive growth and a phenotype com-
mon to DNA replication mutations (2–4). FEN1 is also a key
nuclease in long-patch base-excision repair, a major pathway in
S. cerevisiae (5–7). FEN1 cleaves a 5 f lap substrate produced by
strand-displacement synthesis during replication or repair.
FEN1 cleavage activity is stimulated by proliferating cell nuclear
antigen (PCNA) (8–10). In eukaryotes, long-patch base-excision
repair was found to be PCNA-dependent (11–13). PCNA encir-
cles the double-stranded region of the flap substrate and im-
proves FEN1 binding to the cleavage site at the base of the
flap (10).
FEN1 has also been implicated in replication fork restart. A
stalled fork can regress into a four-way junction called a chicken
foot, which is structurally equivalent to a Holliday recombination
junction (14, 15). The regression provides a mechanism of
damage repair. Werner’s protein unwinds this intermediate and
creates a substrate for FEN1 (16). The Werner’s protein–FEN1
interaction stimulates FEN1 to cleave the strands necessary to
restore replication fork structure.
DNA damage evokes a cellular response that inhibits DNA
replication but allows DNA repair (17). The damage response in
eukaryotic cells involves activation of the ATM and ATR
proteins. The ATM and ATR kinases activate checkpoint control
proteins. ATM is activated in response to double-strand breaks,
whereas ATR is activated in response to stalled replication forks
and to a variety of damage that causes distortions and single
strands (18). Rad9–Rad1–Hus1 (9-1-1) is a toroidal molecule
that is loaded onto DNA by Rad17–RFC, a variation of the
traditional clamp loader RFC (19). The 9-1-1 complex and ATR
are recruited independently to damaged sites (20). The current
model suggests that the 9-1-1 complex and ATR act as damage
sensors and, therefore, participate in the activation of proteins
that promote cell survival.
The damage response also induces the transcription factor
p53, which increases the production of p21, causing growth arrest
(17, 21). The p21 protein has two domains. The amino terminus
inhibits cyclin-dependent kinases, and the carboxyl terminus
binds and inhibits PCNA (22–26). Expression of the PCNA-
binding domain alone is sufficient to cause arrest of cells in G1
(21, 25, 27). This arrest is presumed to result from disruption of
the interaction between DNA polymerase  (pol ) and PCNA
that is necessary for highly processive DNA synthesis (26, 28).
The p21 protein can also interfere with FEN1–PCNA interac-
tions in vitro and in vivo (29). Furthermore, we have shown that
concentrations of the PCNA-inactivating peptide that render pol
 ineffective also prevent PCNA stimulation of FEN1 (30).
It is not clear how the inhibitory functions of p21 relate to
DNA repair. Some results suggest that expression of p21 is
compatible with, or even important for, DNA repair. For
example, mice deficient in p21 are highly sensitive to radiation
(31). Furthermore, cells expressing p21 have increased ability to
repair damaged plasmids (32). If PCNA’s stimulatory function is
compromised by damage-related induction of p21, perhaps the
residual functions of FEN1 are sufficient for repair. Alterna-
tively, we hypothesized that another molecule may be a damage-
specific substitute for PCNA. The 9-1-1 checkpoint complex and
the Rad17–RFC resemble the RFC clamp loader and PCNA,
both structurally and functionally (19, 33–36). We considered
whether the 9-1-1 complex could be a PCNA substitute.
Materials and Methods
Substrate Preparation. Oligonucleotide substrates from Midland
Certified Reagents (Midland, TX) or Integrated DNA Technol-
ogies (Coralville, IA) were designed to mimic DNA replication
and repair intermediates with an upstream primer annealed to
the 3 end of a template and a downstream primer annealed to
the 5 end of a template. Sequences are listed in Table 1. The
primer sequences are listed 5 to 3 and the template sequences
are listed 3 to 5 to facilitate visual alignment. For any flap
substrate, the unannealed region is measured from the 5 end of
the downstream primer. Upstream primer U1 and downstream
primers D1 through D5 were 5-labeled by T4 polynucleotide
kinase (Roche Molecular Biochemicals) by using [-32P]ATP
(PerkinElmer). Downstream primers D6 and D7 were 3-labeled
by annealing 20 pmol of primer to 50 pmol of template contain-
ing a G overhang at the 5 end. [-32P]dCTP (PerkinElmer) was
added to the 3 end of the primer with the Klenow fragment of
Escherichia coli DNA polymerase I (Roche Molecular Biochemi-
cals). Labeled primers were purified by electrophoresis and
isolation from a 15% polyacrylamide7 M urea gel.
Abbreviations: 9-1-1, Rad9–Rad1–Hus1; FEN1, flap endonuclease 1; NER, nucleotide exci-
sion repair; pol , human DNA polymerase ; PCNA, proliferating cell nuclear antigen.
†W.W., P.B., and M.L.R. contributed equally to this work.
¶To whom correspondence should be addressed. E-mail: robertbambara@urmc.
rochester.edu.
© 2004 by The National Academy of Sciences of the USA
16762–16767  PNAS  November 30, 2004  vol. 101  no. 48 www.pnas.orgcgidoi10.1073pnas.0407686101
To anneal substrates, primers were incubated at 95°C for 5
min, transferred to 70°C, and then slowly cooled to room
temperature in annealing buffer containing 10 mM TrisHCl (pH
8.0) and 1 mM EDTA. Substrate used for the pol  assay was
annealed in a 1:2 ratio of labeled upstream primer to template.
Substrates used for FEN1 assays were annealed in a 1:2:4 ratio
of labeled downstream primer to template to upstream primer
with the exception of the double-f lap substrate D6T2U7 and
bubble substrate D7T5U6, which were annealed in a ratio of
1:2:5 under conditions described in ref. 37.
Stimulation of FEN1 Cleavage. FEN1 (38), PCNA (39), pol  (39),
and 9-1-1 (40) were prepared as previously described. Twenty-
microliter reaction mixtures containing the indicated quantities
of enzymes and 5 fmol of 5 32P-radiolabeled DNA substrate
were incubated at 37°C for 3 min, then the reactions were
stopped with 20 l of 2 termination dye [90% formamide
(volvol) with 10 mM EDTA, 0.1% bromophenol blue, and 0.1%
xylene cyanole]. The reaction buffer contained 30 mM Hepes–
NaOH (pH 7.5), 0.1 mgml BSA, 4 mM MgCl2, and 40 mM KCl.
After termination, samples were heated at 95°C for 5 min and
loaded onto a preheated denaturing (7 M urea) 15% polyacryl-
amide gel. After electrophoresis, the gel was dried and scanned
by using a Molecular Dynamics PhosphorImager to detect
products. Pixel densities were determined by using IMAGEQUANT
version 1.2 software (Molecular Dynamics).
Stimulation Time-Course Reaction. A control reaction mixture
containing 11 fmol of FEN1 in 110 l of reaction buffer [30 mM
Hepes–NaOH (pH 7.5)40 mM KCl4 mM MgCl20.1 mg/ml
BSA0.1% Nonidet P-400.1 M DTT] was initiated at time 0 by
adding 110 l of reaction buffer containing 5.5 fmol of the
indicated substrate. Reaction temperature was 37°C. At times 24
sec, 36 sec, 48 sec, 1 min, 1.2 min, 1.8 min, 2.2 min, 2.8 min, and
3.6 min, 20 l of reaction mixture was removed and mixed with
20 l of 2 termination dye. Another reaction of 9-1-1 complex
was carried out in parallel by mixing 110 l of reaction buffer
containing 11 fmol of FEN1 and 220 fmol of 9-1-1 complex with
110 l of reaction buffer containing 5.5 fmol of the indicated
substrate at time 0. At the same times noted above, 20 l of
reaction volume was removed and mixed immediately with 20 l
of 2 termination dye. After termination, samples were heated
at 95°C for 5 min and loaded onto a preheated denaturing (7 M
urea) 15% polyacrylamide gel. The gel was dried and scanned by
PhosphorImager to detect products. Pixel densities were deter-
mined by using IMAGEQUANT.
FEN1 Cleavage of a Blocked Flap Substrate. Substrate D4T1U5 (10
fmol) with 5 biotinylation on T1 and U5 was incubated with
streptavidin (500 fmol) for 20 min on ice in reaction buffer
containing 30 mM Hepes–NaOH (pH 7.5), 0.1 mgml BSA, 4
mM MgCl2, and 40 mM KCl. Unblocked substrate (minus
streptavidin) and blocked substrate (plus streptavidin) were then
incubated with FEN1 (4 fmol) and either PCNA or 9-1-1 for 3
min at 37°C in the same reaction buffer. Reactions were stopped
by the addition of 10 l of 2 termination dye and heated at 95°C
for 5 min. Denatured reaction products were separated on a 12%
polyacrylamide7 M urea gel. The gel was scanned by using a
PhosphorImager and analyzed with IMAGEQUANT.
Coimmunoprecipitation of 9-1-1 and FEN1. Immunoprecipitation
was performed according to standard methods. Briefly, protein
G-Sepharose beads (Sigma) were equilibrated with cell-lysis
buffer [10 mM Hepes (pH 7.6)150 mM KCl10 mM MgCl250
g/ml digitonin] (41) containing 0.1 mM PMSF, and a Protease
Inhibitor Mixture tablet (Roche Diagnostics). RAD1 goat poly-
clonal antibody (Santa Cruz Biotechnology) was mixed with
protein G-Sepharose beads in 500 l of lysis buffer and rotated
for 1 h at 4°C. Then, precleared HeLa cell lysate containing 1 mg
of total protein was added and the mixture was rotated for 1 h
at 4°C. After sedimentation, the supernatant fluid was discarded
and the beads were washed three times with lysis buffer. The
Table 1. Oligonucleotide sequences
Primer Length, nt Oligonucleotide sequence

























*The underlined nucleotide indicates biotin modification when noted in Materials and Methods.








beads were then boiled in sample buffer [62.5 mM TrisCl (pH
6.8)5% glycerol2% SDS0.02% bromophenol blue]. The im-
munoprecipitates were separated by SDS10% PAGE. Western
blot analysis was performed with anti-FEN1 polyclonal antibody
(Novus Biologicals, Littleton, CO) and anti-RAD1 polyclonal
antibody.
pol  Stimulation Assays. Substrate (5 fmol) was incubated with pol
 (1.7 units) and either PCNA or 9-1-1 in buffer containing 40
mM TrisHCl (pH 7.5), 0.2 mgml BSA, 1 mM DTT, 4 mM
MgCl2, 1 mM ATP, and 50 M each dNTP for 8 min at 37°C.
A control reaction with 2units of Klenow fragment of E. coli
DNA polymerase I was incubated in the same buffer for 8 min
at 37°C to produce and mark the position of full-length synthesis
product. Reactions were stopped by the addition of 10 l of 2
termination dye and incubation for 5 min at 95°C. Denatured
reaction products were separated on a 10% polyacrylamide7 M
urea gel. Gels were scanned by PhosphorImager and analyzed
with IMAGEQUANT.
Results
9-1-1 Checkpoint Complex Stimulates FEN1 Cleavage Uniformly Over
Time on Substrates with Various Length Flaps. We hypothesized that
the 9-1-1 complex is the repair-specific substitute for PCNA in
stimulating FEN1. If true, 9-1-1 should stimulate FEN1 on a
gamut of potential substrates present at repair sites. We tested
the capacity of 9-1-1 to stimulate FEN1 on substrates with a
range of flap lengths as well as on nicked and gapped substrates.
9-1-1 complex stimulated FEN1 cleavage on all of these sub-
strates between 10- and 50-fold. Fig. 1A demonstrates that
increasing 9-1-1 concentration stimulates FEN1 cleavage of a
27-nt flap composed of oligonucleotides D5, T3, and U4. The
difference between FEN1 alone (lane 3) and FEN1 with 500
fmol of 9-1-1 complex (lane 7) is between 40- and 50-fold. Fig.
1 B–E shows the quantified results of 9-1-1 stimulation on
substrates with 27-, 25-, 10- and 1-nt flap lengths, respectively,
and Fig. 1F shows 9-1-1 stimulation on a nicked and 1-nt gap
substrate.
To determine whether stimulation by 9-1-1 was uniform over
the course of the reaction, we performed a FEN1-cleavage time
course in the absence and presence of 9-1-1. Fig. 2A shows a scan
of the polyacrylamide gel and Fig. 2B shows the quantified
results demonstrating uniform stimulation throughout the 3.6-
min course of the reaction.
9-1-1 Stimulates FEN1 Cleavage on Substrates with Different Config-
urations of Upstream Primer. FEN1 is known to be active on flap
substrates with different upstream primer characteristics. We
showed previously (42) that the preferred FEN1 substrate is a
double-f lap substrate containing a 1-nt tail on the 3 end of the
upstream primer in addition to the 5 f lap of the downstream
primer. Nick flaps that do not contain a 1-nt 3 tail on the
upstream primer are also cleaved by FEN1. Substrates with a 1-nt
gap (hereafter called ‘‘gap flaps’’) between the upstream primer
and the first annealed nucleotide of the downstream primer show
greatly diminished cleavage activity. Previous work (10) showed
that PCNA stimulates FEN1 activity on all three classes of flap
substrates. We tested whether the 9-1-1 complex stimulates
FEN1 activity similarly. Fig. 1 B–E demonstrates that 9-1-1
stimulates the activity of FEN1 on double flaps, nick flaps, and
gap flaps of four distinct sequences and lengths.
Blocking the Double Strands Prevents a Portion of the Stimulation.
PCNA can stimulate cleavage by FEN1 on a flap substrate with
a linear double-stranded region because the toroidal PCNA
molecule can slide over the end of the double strand. Blocking
the ends of the double-strand region with biotin–streptavidin
prevents stimulation by PCNA (43). When we used a biotin–
streptavidin-blocked flap substrate, PCNA stimulation of FEN1
activity was substantially reduced (Fig. 3, lanes 5 and 6 compared
with lanes 10 and 11). Furthermore, the same substrate reduced
stimulation of FEN1 cleavage by 9-1-1 (Fig. 3, lanes 7 and 8
compared with lanes 12 and 13). A residual stimulation was seen
with both rings and was greater with 9-1-1. Some residual
stimulation probably occurs because the substrate is not totally
biotinylated. At least some stimulation by 9-1-1 appears to occur
by a mechanism independent of loading onto the double strands.
Maximum stimulation by both PCNA and 9-1-1 requires sub-
stantial stoichiometric excess of the ring proteins with the linear
substrates used here. This required excess is evidently because
the rings must enter the substrate by sliding over the double-
stranded ends, rather than through the clamp-loading process
used in vivo. Overall results indicate that 9-1-1 may stimulate
FEN1 by entering the double strands or through a direct binding
mechanism.
Fig. 1. 9-1-1 stimulates FEN1 activity on a variety of substrates. (A) FEN1
cleavage on a 27-nt nick flap (D5T3U4, shown schematically at the top with *
indicating 32P) in the presence of increasing 9-1-1. Reaction mixtures with
FEN1 contain 0.5 fmol of FEN1. Lane 2 contains 500 fmol of 9-1-1. Lanes 4–7
contain 50, 100, 200, and 500 fmol of 9-1-1. (B) FEN1 stimulation by 9-1-1 on
a 27-nt flap with various upstream primers. Short-dashed line, 27-nt double
flap (df) (D5T3U7); solid line, 27-nt nick flap (nf) (D5T3U4); long-dashed line,
27-nt gap flap (gf) (D5T3U2). (C) FEN1 stimulation by 9-1-1 on a 25-nt flap with
various upstream primers. Short-dashed line, 25-nt double flap (D4T1U8); solid
line, 25-nt nick flap (D4T1U5); long-dashed line, 25-nt gap flap (D4T1U3). (D)
FEN1 stimulation by 9-1-1 on a 10-nt flap with various upstream primers.
Short-dashed line, 10-nt double flap (D5T4U7); solid line, 10-nt nick flap
(D5T4U4); long-dashed line, 10-nt gap flap (D5T4U2). (E) FEN1 stimulation by
9-1-1 on a 1-nt flap with various upstream primers. Short-dashed line, 1-nt
double flap (D2T1U8); solid line, 1-nt nick flap (D2T1U5); long-dashed line, 1-nt
gap flap (D2T1U3). (F) FEN1 stimulation on a nicked and gapped substrate.
Solid line, nicked substrate (D1T1U5); long-dashed line, gapped substrate
(D1T1U3).
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As with PCNA, 9-1-1 Cannot Alter the FEN1 Tracking Mechanism. We
previously demonstrated that, although PCNA could augment
FEN1-cleavage activity, it could not subvert the requirement for
FEN1 to enter flaps from the 5 end and track to the point of
cleavage (10). This inability was demonstrated by using bubble
substrates in which the 5 end of the flap was annealed to the
template. Using a similar bubble substrate, we examined the
ability of PCNA and 9-1-1 to stimulate FEN-1.
Both PCNA and 9-1-1 were able to stimulate FEN1 cleavage
of a 27-nt flap substrate (Fig. 4, lanes 4 and 5 and lanes 14 and
15). The bubble substrate is refractory to cleavage by FEN1
(lanes 8 and 18). As shown previously, PCNA cannot overcome
the inhibitory effects of the annealed 5 end (lanes 9 and 10).
Similarly, 9-1-1 cannot activate FEN1 to use the bubble substrate
(lanes 19 and 20). In this manner 9-1-1 behaves similarly to
PCNA, in that it cannot alter the substrate entry mechanism of
FEN1.
The 9-1-1 Complex Interacts with FEN-1. Because the 9-1-1 complex
stimulated FEN1 activity, we anticipated that the two proteins
would display a detectable affinity. We detected interaction by
coimmunoprecipitation of 9-1-1 and FEN-1 from HeLa cell
lysates. As shown in lane 2 of Fig. 5 Upper, immunoprecipitation
with anti-hRad1 antibody successfully captured hFEN-1; how-
ever, we do not know whether this interaction is direct or
mediated by one of the other proteins in the 9-1-1 ring.
9-1-1 Fails to Stimulate pol  Synthesis. Specificity of the damage
response would predict that inactivation of PCNA by p21 would
prevent active and processive synthesis by pol . Furthermore,
9-1-1 should not substitute for PCNA in promoting DNA
synthesis. We tested whether the 9-1-1 stimulates replication by
pol  in a manner similar to PCNA stimulation. DNA synthesis
was measured on a primer–template substrate by observing
Fig. 2. 9-1-1 uniformly stimulates FEN1 cleavage. (A) Stimulation of FEN1
cleavage was assayed in a time-course reaction (0–3.6 min) in the absence or
presence of 9-1-1 on a 27-nt-nick flap substrate (D5T3U4) as described in
Materials and Methods. The starting material is 55 nt, and the 27-nt product
marks the FEN1 cleavage of the flap. (B) Quantified results of stimulation time
course. Œ, FEN1 alone control; , FEN1 and 9-1-1 complex together. Stimula-
tion at each time point was 10- to 15-fold.
Fig. 3. Blocking 9-1-1 entry to the double strands prevents a portion of the
stimulation. Stimulation of FEN1 cleavage was assayed on unblocked (lanes
1–8) and blocked (lanes 9–13) 25-nt nick-flap substrates (D4T1U5) in the
presence of increasing amounts of PCNA (3 or 6 pmol) or 9-1-1 (40 or 80 fmol)
as described in Materials and Methods. The starting material is 43 nt, and FEN1
cleavage of the flap is marked by the 25- and 24-nt products. On unblocked
substrate, the band densities of lanes 5–8 are 6, 9, 2, and 8, respectively,
relative to FEN1 alone in lane 4. On blocked substrate, the band densities of
lanes 10–13 are 2.5, 2, 1.5, and 4, respectively, relative to FEN1 alone in
lane 9.
Fig. 4. 9-1-1 does not stimulate FEN1 cleavage of a bubble substrate. Ten
microliters of substrate (10 fmol) with a 37-nt flap or 24-nt bubble was mixed
with 10 l of enzymes containing 1 fmol of FEN1 and increasing amounts of
PCNA (3 or 6 pmol) or 9-1-1 (0.5 or 1 pmol). The reactions took place at 37°C
for 10 min. The ramps denote the different amounts of PCNA or 9-1-1. The *
indicates the radiolabeled position. The sizes of substrate and cleavage prod-
uct are indicated by arrows. The substrate shown in lanes 1–5 and 11–15 is
derived from the annealing of D6T3U7. The substrate shown in lanes 6–10 and
16–20 is from the annealing of D7T5U6. The addition of PCNA to a flap
substrate augments the cleavage product (lanes 4 and 5) compared with that
of FEN1 only (lane 3). As with PCNA, more cleavage products are observed
after addition of 9-1-1 (lanes 14 and 15) compared with those with FEN1 only
(lane 13). The addition of PCNA (lanes 9 and 10) or 9-1-1 (lanes 19 and 20) to
the bubble substrate does not lead to a visible cleavage product.








extension of a labeled upstream primer in the presence of either
PCNA or 9-1-1 (Fig. 6). The position of the full-length primer-
extension product is marked by reaction of the substrate with an
excess Klenow fragment of E. coli DNA polymerase I (Fig. 6,
lane 1). Incubation of the substrate with pol  alone does not
show synthesis to the end of the template (Fig. 6, lane 4). Yet,
with addition of increasing amounts of PCNA, pol  extends
some products to the end of the template (Fig. 6, lanes 5–9).
Full-length synthesis is stimulated substantially by PCNA (Fig. 6,
lanes 5–9); however, addition of increasing amounts of 9-1-1 has
only a minimal effect on product size distribution (Fig. 6, lanes
11–15). Only at the highest concentration of 9-1-1 (Fig. 6, lane
15) is there a slight stimulation of pol , generating about 50%
more processive synthesis to the end of the template.
Discussion
We show that the 9-1-1 complex interacts with FEN1 and
stimulates its cleavage activity. Because 9-1-1 has been charac-
terized as a DNA damage sensor (17), this result suggests that the
stimulation relates to roles of FEN1 in DNA damage repair.
Moreover, 9-1-1 resembles PCNA in that it is a toroid that
encircles double-stranded DNA. The 9-1-1 complex stimulates
FEN1 on the full range of substrates that respond to PCNA. The
9-1-1 complex may stimulate by entering the double-strand
region or by direct interaction with FEN1. Also, just as with
PCNA, the 9-1-1 complex can augment FEN1-cleavage activity
but not change the need for FEN1 to enter the substrate from
the 5 end of the flap. On the basis of these properties, we
propose that 9-1-1 acts as a damage-specific substitute for
PCNA. When might FEN1 use 9-1-1 in place of PCNA? Acting
as a damage sensor, 9-1-1 may gather at damage sites in
preference to PCNA. Then FEN1 would use the 9-1-1 molecules
to improve its interaction with any damage site at which a 9-1-1
complex is residing. In this model, FEN1 uses a PCNA platform
during replication and the 9-1-1 platform for repair.
Additionally, 9-1-1 may replace PCNA when the active PCNA
concentration is low, as might occur during induction of p21. The
ability of p21 to produce a G1 arrest and to inhibit DNA
replication by preventing PCNA from acting as the sliding clamp
for pol  suggests a role of p21 in the inhibition of replication.
The effects of p21 induction on DNA repair are much less clear.
Some results suggest that p21 does not influence repair and
include observations that p21 does not inhibit repair of UV
damage in human colon carcinoma cells (44–47) and human
bladder cells (47). In fact, in both normal (32) and tumor (44)
cells, deletion of the p21 gene reduced nucleotide excision repair
(NER) capacity. One report shows modest inhibition of NER
after introduction by electroporation of the PCNA-binding
domain of p21 (48). Some results in vitro also show that NER is
insensitive to p21 (49, 50), whereas another result indicates
sensitivity (51). Another indication of the complexity of the role
of p21 is the recent observation (52) that p21 is degraded within
several hours of irradiation via the ubiquitinproteosome path-
way. This observation suggests that cell-cycle arrest is main-
tained by a more involved process than the p21 pathway. It is
unclear whether bound PCNA is also degraded with the p21;
however, the disappearance of p21 would then allow for the
restoration of PCNA.
PCNA is necessary for the structural integrity and function of
replication forks. Uncoupling of the polymerase from the sliding
clamp is sufficient to stop replication (53–55). The 9-1-1 ring did
not activate pol  for processive DNA synthesis. This finding
confirms other recent results (56) and supports the idea that
inactivation of PCNA is sufficient to stop replication-fork pro-
gression. Therefore, 9-1-1 would not be able to reverse inacti-
vation of DNA replication caused by PCNA depletion during the
damage response. FEN1 is involved in both DNA replication and
repair. The 9-1-1 protein can stimulate FEN1, but without
Fig. 6. 9-1-1 fails to stimulate pol  synthesis. Synthesis by pol  was assayed
in the presence of increasing amounts of PCNA (10, 50, 100, 200, and 500 fmol)
or 9-1-1 (10, 50, 100, 200, and 500 fmol) on a primer–template substrate (T6U1)
as described in Materials and Methods. The 20-nt band marks the labeled
primer, and the 110-nt product marks pol  full-length extension of the
upstream primer.
Fig. 5. 9-1-1 interacts with FEN1. Immunoprecipitation was performed as
described in Materials and Methods. HeLa cell extract was immunoprecipi-
tated (IP) with anti-human (h)Rad1 polyclonal antibody. Lane 1, whole cell
lysate mixed only with protein G-Sepharose beads (mock immunoprecipita-
tion containing no antibody). Lane 2, immunoprecipitation with anti-hRad1
antibody. The weak band larger than hFEN1 in Upper and the weak band
smaller than hRad1 in Lower are antibody IgG heavy chain and light chain,
respectively. Lane 3, supernatant fluid of third wash after immunoprecipita-
tion. Lane 4, whole cell lysate control. Lane 5, purified recombinant human
FEN1 control. Lane 6, purified recombinant human Rad1 control. Upper is
blotted with anti-hFEN1 polyclonal antibody; Lower is blotted with anti-
hRad1 antibody. Arrows indicate the positions of endogenous hFEN1 and
hRad1. The band indicated by an asterisk is likely partially degraded recom-
binant hRad1. Because purified recombinant hFEN1 contains a His6 tag, and
purified recombinant hRad1 is tagged with a Flag-cAMP kinase motif, the sizes
of both proteins are larger than endogenous hFEN1 and hRad1 (19).
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processive pol , the activated FEN1 will be confined to repair
functions.
Our results indicate that 9-1-1 serves a dual role as a damage
sensor and as a component of repair complexes. Stimulation of
FEN1 by 9-1-1 raises the possibility that 9-1-1 could be a
universal platform for DNA repair, just as PCNA serves such a
role for replication. In this hypothesis, 9-1-1 would substitute for
PCNA in all of its repair roles. For example PCNA is a
component of the NER pathway (17). PCNA also stimulates the
joining activity of DNA ligase I (57), thought to participate in
long-patch base-excision repair. This concept suggests the likely
value of determining the capacity for stimulation of a wider
variety of repair proteins by 9-1-1.
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